How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Agriculture · Forecast 2027–2033
Plants Molecular Breeding Market
- By Technology: Marker-Assisted Selection (MAS), Genomic Selection (GS), Transgenic Breeding, Genome Editing (CRISPR/Cas9), RNA Interference (RNAi)
- By Crop Type: Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables, Fiber Crops, Forage & Turf
- By Application: Yield Improvement, Disease Resistance, Abiotic Stress Tolerance, Quality Enhancement, Nutritional Improvement
- By End User: Seed Companies, Agricultural Biotechnology Firms, Research Institutions, Contract Research Organizations (CROs), Government Agencies
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Marker-Assisted Selection (MAS) leads By Technology at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 281 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Plants Molecular Breeding Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Technology 5
Crop Type 5
Application 5
End User 5
Companies profiled
BASF SE
Bayer Crop Science
Syngenta AG
Corteva Agriscience
KWS SAAT SE
Limagrain
Mitsubishi Chemical Holdings Corporation
Dow AgroSciences
DuPont Pioneer
BASF Plant Science
Evogene Ltd.
KeyGene N.V.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Bayer Crop Science
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Syngenta AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Corteva Agriscience
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →KWS SAAT SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Limagrain
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Mitsubishi Chemical Holdings Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Dow AgroSciences
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →DuPont Pioneer
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →BASF Plant Science
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Evogene Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →KeyGene N.V.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Arcadia Biosciences
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Inari Agriculture
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Pairwise Plants
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,406M by 2033 · 5.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Marker-Assisted Selection (MAS)37.0
- Genomic Selection (GS)21.0
- Transgenic Breeding11.8
- Genome Editing (CRISPR/Cas9)11.3
- RNA Interference (RNAi)18.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,566M → $2,220M · 4.5%
Europe$1,092M → $1,590M · 4.8%
Asia Pacific$996.8M → $1,382M · 4.2%
Latin America$617.1M → $966.4M · 5.8%
Middle East and Africa$474.7M → $712.0M · 5.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.662026
5.692027
5.692028
5.702029
5.722030
5.742031
5.742032
5.752033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BASF SE14.0
- Bayer Crop Science18.9
- Syngenta AG11.3
- Corteva Agriscience5.9
- KWS SAAT SE13.1
- Limagrain8.9
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Technology15.0%
Crop Type21.2%
Application29.0%
End User34.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.3
- Europe23.1
- Asia Pacific20.1
- Latin America14.1
- Middle East and Africa10.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BASF SE | 77 | 94 | 91 | 83 | 85 | 76 | 84 |
| Bayer Crop Science | 92 | 83 | 82 | 84 | 75 | 76 | 82 |
| Syngenta AG | 84 | 83 | 74 | 76 | 83 | 74 | 79 |
| Corteva Agriscience | 82 | 82 | 80 | 76 | 73 | 64 | 76 |
| KWS SAAT SE | 62 | 53 | 70 | 74 | 67 | 64 | 65 |
| Limagrain | 60 | 58 | 54 | 65 | 62 | 54 | 59 |
| Mitsubishi Chemical Holdings Corporation | 58 | 49 | 50 | 50 | 43 | 62 | 52 |
| Dow AgroSciences | 56 | 56 | 52 | 50 | 41 | 38 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BASF SE
- Bayer Crop Science
- Syngenta AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BASF SE | ✓ | ◐ | ✓ | ✓ | ✓ | ◐ |
| Bayer Crop Science | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Syngenta AG | ◐ | ◐ | ✓ | ✓ | ✓ | ◐ |
| Corteva Agriscience | ◐ | ✓ | ◐ | ◐ | ✓ | ◐ |
| KWS SAAT SE | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| Limagrain | ◐ | ◐ | − | − | ✓ | ◐ |
| Mitsubishi Chemical Holdings Corporation | ◐ | − | − | ◐ | − | ◐ |
| Dow AgroSciences | ◐ | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1BASF SE84
2Bayer Crop Science82
3Syngenta AG79
4Corteva Agriscience76
5KWS SAAT SE65
6Limagrain59
7Mitsubishi Chemical Holdings Corporation52
8Dow AgroSciences49
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
BASF SEBayer Crop ScienceSyngenta AG
Challenger1
Strong scale, closing on the leaders.
Corteva Agriscience
Contender2
Focused players with pockets of strength.
KWS SAAT SELimagrain
Niche2
Specialists in a single segment or region.
Mitsubishi Chemical Holdings CorporationDow AgroSciences
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Technology in North America, then scale across Plants Molecular Breeding Market — a $274M beachhead inside a $4.86B market.
Beachhead (SOM)$274Mobtainable near-term
Serviceable (SAM)$1.69Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Marker-Assisted Selection (MAS)
Best fit — highest urgency & budget in Technology.
Economic buyer79 fit
Genomic Selection (GS)
Strong fit — clear ROI and a fast path to value.
End user65 fit
Transgenic Breeding
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Technology in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Crop Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel26%
Digital / self-serve23%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Technology leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Plants Molecular Breeding Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified21%
Evaluation15%
Closed-won7%
$12.0KCAC
$72KLTV
6.0:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Plants Molecular Breeding Market is a resilient opportunity — $2.68B by 2033, compounding at 4.4%.
TAM · 2025$1.90Btoday
TAM · 2033$2.68Bforecast
CAGR4.4%2027–2033
Cumulative$20.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.68BTotal addressable market
SAM$1.10BServiceable available market
SOM$180MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.4% CAGR
Demand compounds through 2033, outpacing GDP across Technology.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Technology moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.68BLarge & growingTAM by 2033 at 4.4% CAGR
$1.10BServiceable nowreachable with today’s model
$180MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.09BBear2.8% CAGR
$2.68BBase4.4% CAGR
$3.43BBull5.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Crop Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Plants Molecular Breeding Market — a $3.85B market by 2033. Plan: grow share from 7.2% to 12.1%.
Market size · 2033$3.85Btotal addressable
Market CAGR9.8%2027–2033
Target share12.1%from 7.2% today
Revenue ambition$465Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.2% | 12.1% | On track |
| Revenue | $295M | $465M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Ahead |
| Gross margin | 31.7% | 41.3% | At risk |
| Customer retention | 88.9% | 95.7% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Technology
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Crop Type capability
A defensible second engine — invest in Crop Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Technology share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Crop Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $54M capacity & capability investment
- Greenlight bolt-on M&A in Crop Type
- Authorise North America expansion plan
- Fund R&D program for Technology leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Plants Molecular Breeding Market conversation — a $2.27B market you can size, segment and defend in minutes.
Market size · 2033$2.27Btotal opportunity
Growth6.1%CAGR to 2033
Addressable buyers1,661+accounts in scope
Typical ROI4.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Technology
Goal Grow share in Technology
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.7×return on cost, year one
< 2 mopayback period
$74K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
BASF SEBayer Crop ScienceSyngenta AGCorteva AgriscienceKWS SAAT SELimagrainMitsubishi Chemical Holdings CorporationDow AgroSciences+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Plants Molecular Breeding Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Plants Molecular Breeding Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Agriculture · scroll →Water Network Management System Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportAquatic Weed and Algae Management Control Services Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportAnimal Cremate Services Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportIndoor Self-growing Garden System Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportAgricultural Wastewater Treatment Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportAgriculture Energy-Saving Cooling and Freezing Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportBiotechnology Algae Cultivation Process Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportWorld Combine Harvesters Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportAutomated Greenhouse Professional Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportOilseed Processing Professional Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportGrain Bin Management Solution Professional Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportAgro-Rural Tourism Professional Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.